|
|
|
|
| LEADER |
00000cam a2200000Mu 4500 |
| 001 |
on1348480949 |
| 003 |
OCoLC |
| 005 |
20240909213021.0 |
| 006 |
m o d |
| 007 |
cr ||||||||||| |
| 008 |
221112s2022 sz o ||| 0 eng d |
| 040 |
|
|
|a EBLCP
|b eng
|c EBLCP
|d OCLCO
|d OCLCQ
|d U3W
|d OCLCO
|d OCLCF
|d OCLCO
|d UEJ
|
| 020 |
|
|
|a 9789280533606
|
| 020 |
|
|
|a 9280533606
|
| 035 |
|
|
|a (OCoLC)1348480949
|
| 049 |
|
|
|a HCDD
|
| 100 |
1 |
|
|a Staff, World Intellectual Property Organization.
|
| 245 |
1 |
0 |
|a COVID-19-related vaccines and therapeutics
|h [electronic resource] :
|b Preliminary insights on related patenting activity during the pandemic.
|
| 260 |
|
|
|a Geneva :
|b World Intellectual Property Organization,
|c 2022.
|
| 300 |
|
|
|a 1 online resource (83 p.)
|
| 500 |
|
|
|a Description based upon print version of record.
|
| 505 |
0 |
|
|a Intro -- _Hlk93048502 -- Acknowledgements -- Key findings -- Introduction -- Background -- biology of COVID-19 -- Overview of patenting activity related to COVID-19 -- Patent filings during 2020-2021 -- Filing and publication of COVID-19-related patent applications over time -- COVID-19-related vaccine and therapeutic patent applicant profiles -- Research collaboration and IP strategies related to technologies important to COVID-19 vaccines and therapeutics -- Disclosure of sequences within patent documents -- COVID-19 vaccines -- Background -- vaccine platforms
|
| 505 |
8 |
|
|a Conventional vaccine platforms -- Novel vaccine platforms -- Patent and vaccine distribution by vaccine platform and published applicant location -- Speed of vaccine development -- COVID-19 vaccine patent landscape -- Core vaccine technologies, collaboration and licensing -- Analysis of WHO data on COVID-19 vaccines -- Timelines on key technologies for COVID-19 vaccine development -- Technologies relevant to mRNA vaccine -- Timeline details for adenovirus vaccine development -- Timeline details for vaccine adjuvant development -- COVID-19 therapeutics -- Background
|
| 505 |
8 |
|
|a Analysis of COVID-19 therapeutics-related patent applications by substances type -- Top locations of patent applicants for COVID-19 therapeutics and their filing strategies -- Highlights of patent filings related to COVID-19 therapeutic development -- Patent filings related to development of small-molecule drugs for COVID-19 -- Patent filings related to the development of biologics for COVID-19 -- Patents related to antibodies for COVID-19 treatment -- Peptide and protein therapies -- Nucleic-acid-based therapies -- Aptamer-mediated therapy -- Cell-based therapies
|
| 505 |
8 |
|
|a Other biologic-based therapies -- Analysis of COVID-19 therapeutics in clinical trials -- Analysis of COVID-19 therapeutics data in the Milken Institute and Regulatory Affairs Professionals Society (RAPS) tracker data -- Distribution of COVID-19 drug candidates across small molecules and biologics, repurposed drugs and de novo synthesized drugs -- Classification of COVID-19 drug candidates in clinical trials by molecular nature and function -- Feature summary of examples of anti-COVID-19 drug candidates in clinical trials -- Perspectives -- Annex -- Data sources and methods
|
| 505 |
8 |
|
|a Tables of vaccine types and candidates currently in clinical trials -- Examples of partial, early disclosure observed at the Israeli, U.K. and Singapore patent offices -- Glossary -- References -- Further reading
|
| 650 |
|
0 |
|a COVID-19 (Disease)
|
| 650 |
|
0 |
|a Patents.
|
| 650 |
|
0 |
|a Patents (International law)
|
| 650 |
|
7 |
|a COVID-19 (Disease)
|2 fast
|
| 650 |
|
7 |
|a Patents
|2 fast
|
| 650 |
|
7 |
|a Patents (International law)
|2 fast
|
| 776 |
0 |
8 |
|i Print version:
|a Staff, World Intellectual Property Organization
|t COVID-19-related vaccines and therapeutics
|d Geneva : World Intellectual Property Organization,c2022
|z 9789280533590
|
| 856 |
4 |
0 |
|u https://ebookcentral.proquest.com/lib/holycrosscollege-ebooks/detail.action?docID=7113890
|y Click for online access
|
| 903 |
|
|
|a EBC-AC
|
| 994 |
|
|
|a 92
|b HCD
|